Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Dull, US

Bob J. Dull, O'Fallon, IL US

Patent application numberDescriptionPublished
20090105335POLYUNSATURATED FATTY ACID MONOVALENT AND DIVALENT METAL SALT SYNTHESIS - Disclosed herein are methods for the preparation of a free-flowing, storage-stable fatty acid metal salt product by forming a reactive admixture comprising (a) an unsaturated fatty acid glyceride feedstock; and (b) from about 1 mol to about 3 mol of at least one monovalent metal hydroxide or at least one divalent metal hydroxide; and heating the admixture to a temperature at which said fatty acid glycerides saponify to form fatty acid metals salts; wherein said monovalent metal is potassium; and wherein said divalent metal is selected from the group consisting of calcium, copper, magnesium and zinc. The fatty acid glycerides may be saponified in an atmosphere in which the partial pressure of oxygen has been reduced by an amount effective to provide an improvement in storage stability until a free-flowing, storage-stage product is obtained, or prior to saponification, the fatty acid glycerides may blended with a stabilizing oil that promotes storage stability, or both. Storage stable metal salts of unsaturated fatty acids prepared by the inventive methods are also disclosed.04-23-2009
20110039932POLYUNSATURATED FATTY ACID MONOVALENT AND DIVALENT METAL SALT SYNTHESIS - Methods for the preparation of a free-flowing, storage-stable fatty acid metal salt product by forming a reactive admixture of (a) an unsaturated fatty acid glyceride feedstock; and (b) from about 1 mol to about 3 mol of at least one monovalent metal hydroxide or at least one divalent metal hydroxide; and heating the admixture to a temperature at which said fatty acid glycerides saponify to form fatty acid metals salts; wherein said monovalent metal is potassium; and wherein said divalent metal is selected from the group consisting of calcium, copper, magnesium and zinc. The fatty acid glycerides are saponified in an atmosphere in which the partial pressure of oxygen has been reduced by an amount effective to provide an improvement in storage stability until a free-flowing, storage-stage product is obtained. Storage stable metal salts of unsaturated fatty acids prepared by the inventive methods are also disclosed.02-17-2011

Bob J. Dull, Akron, OH US

Patent application numberDescriptionPublished
20110070344Tandem Use of Catholyte and Anolyte to Clean and Sanitize Fruit and Vegetables - A method for de-soiling and disinfecting produce, the method including: treating the produce with a catholyte solution to yield a catholyte treated produce; sonicating the catholyte treated produce to yield a sonicated produce; and treating the sonicated produce with an anolyte solution.03-24-2011

Patent applications by Bob J. Dull, Akron, OH US

Bob Jay Dull, Akron, OH US

Gary M. Dull, Lewisville, NC US

Patent application numberDescriptionPublished
20100048643Novel Polymorph Forms Of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine - Polymorph forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine p-hydroxybenzoate, and methods for their preparation, pharmaceutical composition containing said polymorph(s) and use, are disclosed. The polymorphs can be administered to patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, to treat and/or prevent such disorders.02-25-2010
20100121061COMPOUNDS CAPABLE OF ACTIVATING CHOLINERGIC RECEPTORS - The present invention generally relates to nicotinic compounds, in the form of aryl substituted olefinic compounds, as well as pro-drug, N-oxide, metabolite and pharmaceutically acceptable salt forms thereof. Methods of modulating neurotransmitter release via administration of the compounds, pro-drugs, N-oxides and/or pharmaceutically acceptable salts are also disclosed.05-13-2010
20100249196Novel Salt Forms Of (2S)-(4E)-N-Methyl-5-[3-(5-Isopropoxypyridin)yl]-4-Penten 2-Amine - Phosphoric acid, edisylic acid (1,2-ethanedisulfonic acid), citric acid, orotic acid (uracil-6-carboxylic acid), R-mandelic acid, sulfuric acid, 1,5-naphthalenedisulfonic acid, D-aspartic acid, and lysine monohydrochloride salts of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine, and methods for their preparation, pharmaceutical compositions comprising said salts, and use, are disclosed. The salts can be administered to patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, to treat and/or prevent such disorders.09-30-2010

Patent applications by Gary M. Dull, Lewisville, NC US

Kenneth M. Dull, Puvallup, WA US

Patent application numberDescriptionPublished
20100291258CURE TOOL WITH INTEGRATED EDGE BREATHER AND METHOD OF MAKING THE SAME - A tool for curing a composite layup comprises a tool body having a surface adapted to support a composite layup thereon. The tool includes an integrated breather for allowing removal of air from the layup during curing.11-18-2010

Kenneth M. Dull, Puyallup, WA US

Patent application numberDescriptionPublished
20090297788METHOD AND APPARATUS FOR MINIMIZING INCONSISTENCIES APPEARING ON A SURFACE OF A COMPOSITE COMPONENT - A method and apparatus for applying a pre-cured composite strip to a composite component. A pre-cured composite strip having a thermoset resin may be placed on a surface of a portion of the composite component where a caul plate seam may be expected. Caul plates may be placed on the composite component after placing the pre-cured composite strip to form the caul plate seam. The composite component may be cured after placing the caul plates on the composite component.12-03-2009
20100024964Method for minimizing fiber distortion during fabrication of one-piece composite barrel section - A method for fabricating a one-piece composite fuselage section that minimizes out-of-plane fiber distortion. This is accomplished by fabricating a mandrel having a coefficient of thermal expansion in the hoopwise direction that is sufficiently greater than that of the laid-up composite ply assembly. As a result of this differential in the coefficients of thermal expansion in the hoopwise direction, the laid-up composite ply assembly is stretched circumferentially as the mandrel expands radially during cure, thereby eliminating or reducing out-of-plane fiber distortion. At the same time, the mandrel and part being fabricated should have substantially the same coefficient of thermal expansion in the lengthwise direction. As the outer surface of the mandrel increases in circumference, the circumferentially oriented reinforcing fibers of the inner plies are stretched, while the circumferentially oriented reinforcing fibers of the outer plies do not reduce in circumference and thus do not form waves or wrinkles.02-04-2010
20100154990COMPOSITE STIFFENER POSITIONING AND VACUUM BAG INSTALLATION DEVICE - A method and apparatus for manufacturing composite parts. An expandable tool with a transfer system may be moved on a surface of the expandable tool into an outer mold line tool with a composite material laid up on the outer mold line tool. The expandable tool may be expanded in the outer mold line tool to change the surface from a retracted state to an expanded state. The transfer system may be transferred from the expandable tool with the surface in the expanded state to the outer mold line tool.06-24-2010
20100170326LEAK DETECTION IN COMPOSITE TOOLS - A device for detecting an air leak in a tool comprises a vacuum bag and a leak detection film disposed along an inside face of the vacuum bag. The leak detection film may include oxygen sensitive material configured to change physical appearance at a location of an air leak in the tool. A breather layer may be interposed between the tool and the leak detection film for facilitating air flow therebetween.07-08-2010

Randal Dull US

Patent application numberDescriptionPublished
20110118362POLYMERS FOR CARDIOPULMONARY THERAPIES - Disclosed are compositions containing copolymers with hydroxypropyl methacrylamide and methods of using the compositions to treat cardiopulmonary diseases are also disclosed.05-19-2011